Clinical Approach to Weakness

Pediatric Neurology Framework

1
Symptom Overview
Overview
2
Pathophysiology
Mechanism
3
History Taking
History
4
Physical Examination
Examination
5
Differential Diagnosis
Differential
6
Investigations
Workup
7
Clinical Decision-Making
Algorithm
8
Pearls and Pitfalls
Summary

1. Symptom Overview

Understanding the clinical significance and classification of weakness in children

Weakness in children is a concerning symptom that prompts approximately 3-5% of pediatric neurology consultations. Unlike adults, children may present with weakness in subtle ways — a toddler who stops walking, an infant with poor feeding due to fatigue, or a school-age child who can no longer keep up with peers. The annual incidence of acute flaccid paralysis in children is approximately 1-2 per 100,000, while chronic neuromuscular disorders affect approximately 1 in 3,500 children. Recognizing true weakness versus other mimics (fatigue, pain, poor coordination) is the critical first step in evaluation.

Definition

Weakness is defined as a reduction in the maximum force that a muscle or muscle group can generate. In pediatrics, this must be distinguished from hypotonia (reduced resistance to passive movement), fatigue (inability to sustain activity over time), and motor delay (failure to achieve age-appropriate motor milestones). True weakness implies pathology somewhere along the motor pathway — from the upper motor neuron in the brain to the muscle fiber itself.

Key Epidemiology

Guillain-Barré syndrome: 0.4-1.4 per 100,000 children annually — most common cause of acute flaccid paralysis
Duchenne muscular dystrophy: 1 in 3,500-5,000 male births — most common inherited muscular dystrophy
Spinal muscular atrophy: 1 in 6,000-10,000 live births — leading genetic cause of infant mortality
Myasthenia gravis: 1-5 per million children — autoimmune neuromuscular junction disorder
Transverse myelitis: 1-4 per million children annually — spinal cord inflammation

Classification by Onset and Duration

The tempo of weakness onset is one of the most critical features in narrowing the differential diagnosis. Acute presentations demand urgent evaluation for potentially life-threatening causes, while chronic weakness requires systematic investigation for neuromuscular disorders.

Category	Duration	Common Causes	Clinical Significance
Hyperacute	Minutes to hours	Stroke, spinal cord compression, botulism, periodic paralysis, tick paralysis	Neurological emergency — immediate imaging and intervention required
Acute	Hours to days	Guillain-Barré syndrome, transverse myelitis, acute viral myositis, electrolyte disturbances	Urgent evaluation — risk of respiratory compromise
Subacute	Days to weeks	Inflammatory myopathies, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy	Requires systematic workup — often treatable conditions
Chronic	Weeks to months	Muscular dystrophies, spinal muscular atrophy, congenital myopathies, hereditary neuropathies	Often genetic — multidisciplinary management required
Episodic	Recurrent episodes with normal intervals	Periodic paralysis, metabolic myopathies, myasthenia gravis	May have normal examination between episodes — history is key

Classification by Anatomical Localization

Determining where along the motor pathway the lesion lies is fundamental to diagnosis. The clinical features differ dramatically between upper motor neuron and lower motor neuron weakness.

Upper Motor Neuron Weakness

Location: Brain or spinal cord (corticospinal tract)

Tone: Increased (spasticity) — may be initially flaccid in acute lesions

Reflexes: Hyperreflexia, clonus, positive Babinski sign

Atrophy: Minimal or late (disuse atrophy)

Distribution: Pyramidal pattern — extensors weaker in upper limbs, flexors weaker in lower limbs

Fasciculations: Absent

Lower Motor Neuron Weakness

Location: Anterior horn cell, nerve root, peripheral nerve, neuromuscular junction, or muscle

Tone: Decreased (flaccidity, hypotonia)

Reflexes: Hyporeflexia or areflexia

Atrophy: Early and prominent (denervation atrophy)

Distribution: Depends on specific nerve or muscle involved

Fasciculations: May be present (anterior horn cell or nerve root pathology)

Classification by Distribution Pattern

The pattern of weakness provides crucial clues to the underlying etiology. Recognizing these patterns accelerates diagnosis and guides investigation.

Pattern	Description	Suggests	Examples in Children
Proximal	Shoulder and hip girdle weakness predominates; difficulty climbing stairs, rising from floor, raising arms overhead	Myopathy (muscle disease)	Duchenne muscular dystrophy, inflammatory myopathies, limb-girdle muscular dystrophies
Distal	Hand and foot weakness predominates; difficulty with fine motor tasks, foot drop	Neuropathy (nerve disease)	Charcot-Marie-Tooth disease, hereditary motor neuropathies
Generalized	Affects all muscle groups relatively equally	Systemic or diffuse process	Spinal muscular atrophy, critical illness myopathy, severe Guillain-Barré syndrome
Focal/Asymmetric	Affects one limb or one side of body	Central nervous system lesion or mononeuropathy	Stroke, brain tumor, brachial plexus injury, mononeuritis multiplex
Bulbar	Face, swallowing, speech affected; may have ptosis, diplopia	Brainstem, neuromuscular junction, or cranial nerve pathology	Myasthenia gravis, botulism, brainstem encephalitis
Fatigable	Weakness worsens with repeated use or throughout the day	Neuromuscular junction disorder	Myasthenia gravis, congenital myasthenic syndromes

Age-Specific Presentations

The presentation of weakness varies significantly with age due to developmental differences and age-specific disease predilections. Understanding these patterns is essential for pediatric evaluation.

Age Group	Common Presentations	Key Conditions to Consider	Developmental Considerations
Neonate (0-28 days)	Hypotonia (“floppy infant”), poor feeding, weak cry, respiratory distress, arthrogryposis	Spinal muscular atrophy type 1, congenital myopathies, congenital muscular dystrophies, congenital myasthenic syndromes, hypoxic-ischemic encephalopathy	Distinguish from normal neonatal hypotonia; assess for dysmorphic features suggesting genetic syndromes
Infant (1-12 months)	Delayed motor milestones, inability to sit, poor head control, “slip-through” on vertical suspension	Spinal muscular atrophy, Pompe disease, congenital myopathies, botulism	Compare to expected milestones: head control by 3-4 months, sitting by 6-8 months
Toddler (1-3 years)	Gait abnormalities, frequent falls, difficulty climbing, Gowers sign, regression of motor skills	Duchenne muscular dystrophy, spinal muscular atrophy type 2-3, metabolic myopathies	Walking typically achieved by 12-18 months; regression is always concerning
School-age (4-12 years)	Difficulty keeping up with peers, sports intolerance, toe-walking, muscle cramps, declining athletic performance	Duchenne/Becker muscular dystrophy, Charcot-Marie-Tooth disease, Guillain-Barré syndrome, juvenile myasthenia gravis	May be first noticed during physical education or organized sports
Adolescent (13-18 years)	Exercise intolerance, fatigability, cosmetic concerns (asymmetry, atrophy), limb-girdle weakness	Limb-girdle muscular dystrophies, facioscapulohumeral muscular dystrophy, myasthenia gravis, inflammatory myopathies	May minimize or hide symptoms; psychological impact significant

The “Floppy Infant” — A Special Consideration:

The hypotonic infant represents a unique diagnostic challenge. The key questions are:

Is the infant weak or just hypotonic? — Hypotonia with weakness suggests neuromuscular disease; hypotonia without weakness (antigravity movements preserved) suggests central nervous system pathology
Is there evidence of central involvement? — Encephalopathy, seizures, dysmorphic features, or abnormal brain imaging suggest central hypotonia
Is there respiratory compromise? — Paradoxical breathing pattern (abdominal breathing with chest wall retraction) suggests diaphragmatic weakness and impending respiratory failure

Impact on Function and Quality of Life

Weakness profoundly affects all aspects of a child’s life — physical development, social participation, educational achievement, and family dynamics. Early recognition and intervention can significantly impact long-term outcomes.

Functional Impact

Delayed motor milestones
Mobility limitations and wheelchair dependence
Respiratory insufficiency requiring support
Feeding difficulties and nutritional compromise
Scoliosis and joint contractures
Reduced physical activity and deconditioning

Psychosocial Impact

Social isolation and difficulty with peer relationships
Academic challenges due to fatigue or absences
Anxiety and depression (child and family)
Impact on siblings and family dynamics
Financial burden on families
Transition planning for adulthood

Key Concept: The Motor Unit

Understanding weakness requires understanding the motor unit — the fundamental functional unit of the motor system consisting of: (1) the anterior horn cell (lower motor neuron cell body), (2) its axon traveling through the nerve root and peripheral nerve, (3) the neuromuscular junction, and (4) all muscle fibers innervated by that neuron. Pathology at any level produces lower motor neuron weakness, but the specific clinical features and investigation findings differ, allowing precise localization.

2. Pathophysiology and Mechanisms

Understanding the underlying mechanisms of weakness in children

To generate voluntary movement, a complex pathway must function intact — from the motor cortex planning the movement, through the corticospinal tract, to the lower motor neuron, across the neuromuscular junction, and finally to the muscle fiber that contracts. Weakness results when any component of this pathway is compromised. Understanding these mechanisms guides both diagnosis and treatment.

The Motor Pathway: From Brain to Muscle

The motor pathway can be conceptualized as a series of relay stations, each with distinct anatomy, physiology, and susceptibility to different disease processes.

Level	Structure	Function	Clinical Features When Affected
Upper Motor Neuron	Motor cortex (precentral gyrus), corticospinal tract (through internal capsule, brainstem, lateral columns of spinal cord)	Initiates and modulates voluntary movement; provides tonic inhibition to spinal reflexes	Spasticity, hyperreflexia, extensor plantar response (Babinski sign), weakness in pyramidal distribution, preserved bulk
Lower Motor Neuron — Anterior Horn Cell	Cell body in ventral horn of spinal cord (or motor nuclei of brainstem for cranial nerves)	Final common pathway — integrates all inputs and generates action potential to muscle	Flaccidity, areflexia, severe atrophy, fasciculations; weakness follows myotomal distribution
Nerve Root	Ventral (motor) root exiting spinal canal	Carries motor axons from anterior horn cells to form peripheral nerves	Myotomal weakness, dermatomal sensory changes if dorsal root involved; pain common
Peripheral Nerve	Mixed sensorimotor nerves or pure motor nerves	Conducts action potentials to neuromuscular junction	Weakness in nerve distribution, sensory loss, distal predominant, areflexia
Neuromuscular Junction	Presynaptic terminal, synaptic cleft, postsynaptic acetylcholine receptors on muscle membrane	Converts electrical signal (nerve action potential) to chemical signal (acetylcholine release) to electrical signal (muscle action potential)	Fatigable weakness, fluctuating symptoms, ocular and bulbar involvement common; reflexes often preserved early
Muscle	Sarcolemma, sarcoplasmic reticulum, contractile apparatus (actin and myosin), mitochondria	Converts electrical signal to mechanical force (excitation-contraction coupling)	Proximal weakness, preserved reflexes until late, no sensory involvement, elevated creatine kinase

Mechanisms of Weakness by Location

Upper Motor Neuron Pathology

Mechanisms

Ischemia/Infarction: Arterial occlusion (pediatric stroke) leads to neuronal death in motor cortex or corticospinal tract.

Inflammation: Demyelination (acute disseminated encephalomyelitis, multiple sclerosis) or direct inflammation (transverse myelitis) disrupts conduction.

Compression: Tumors, abscesses, or hematomas compress corticospinal tract fibers.

Degeneration: Hereditary spastic paraplegias — progressive degeneration of longest corticospinal tract axons.

Why Spasticity Develops

Upper motor neurons normally provide tonic inhibition to spinal stretch reflexes. When this inhibition is lost:

Stretch reflexes become hyperactive (hyperreflexia)
Muscle tone increases (spasticity)
Clonus may develop (rhythmic contractions)
Babinski sign emerges (loss of normal plantar flexion reflex)

Note: Acutely, upper motor neuron lesions may cause flaccidity (“spinal shock”) before spasticity develops.

Anterior Horn Cell Pathology

Condition	Mechanism	Clinical Features	Pediatric Considerations
Spinal Muscular Atrophy	Mutation in SMN1 gene → deficiency of survival motor neuron protein → progressive degeneration of anterior horn cells	Progressive proximal weakness, hypotonia, areflexia, tongue fasciculations, relative sparing of facial muscles and diaphragm early	Now detectable by newborn screening; disease-modifying therapies available (nusinersen, onasemnogene, risdiplam) — early treatment critical
Poliomyelitis	Poliovirus selectively infects and destroys anterior horn cells	Acute flaccid paralysis, asymmetric, lower limbs more than upper, no sensory involvement	Rare due to vaccination; consider in unvaccinated or immunocompromised; part of acute flaccid myelitis differential
Acute Flaccid Myelitis	Viral infection (often enterovirus D68 or A71) causes inflammation of anterior horn cells	Acute limb weakness, often asymmetric, may have preceding respiratory illness, MRI shows gray matter T2 hyperintensity	Emerged as important cause of acute weakness in children; seasonal (late summer/fall); variable recovery

Why Fasciculations Occur

Fasciculations — visible spontaneous twitching of muscle — are characteristic of anterior horn cell disease. They occur because:

Dying motor neurons become hyperexcitable and fire spontaneously
Denervated muscle fibers are reinnervated by collateral sprouting from surviving neurons, creating larger motor units that produce visible twitches
In children with spinal muscular atrophy, tongue fasciculations are a classic finding — look carefully with the tongue at rest in the mouth

Peripheral Nerve Pathology

Axonal Neuropathies

Mechanism: Primary damage to the axon itself — the nerve fiber that conducts signals.

Causes: Genetic (Charcot-Marie-Tooth type 2), toxic, metabolic, or ischemic injury.

Features:

Length-dependent pattern — longest axons affected first (distal weakness and sensory loss)
Wallerian degeneration distal to injury
Slow recovery (requires axonal regeneration at 1-3 mm/day)

Demyelinating Neuropathies

Mechanism: Damage to myelin sheath that insulates axons and enables rapid saltatory conduction.

Causes: Autoimmune (Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy), genetic (Charcot-Marie-Tooth type 1).

Features:

Conduction block — signals fail to propagate past demyelinated segments
Slowed conduction velocity
Better prognosis for recovery (remyelination faster than regeneration)

Condition	Mechanism	Treatment Implication
Guillain-Barré Syndrome	Molecular mimicry — antibodies to preceding infection cross-react with gangliosides on peripheral nerve myelin or axons → complement-mediated nerve damage	Intravenous immunoglobulin or plasmapheresis removes pathogenic antibodies; early treatment improves outcomes
Charcot-Marie-Tooth Disease Type 1	Mutations in genes encoding myelin proteins (PMP22, MPZ) → abnormal myelin formation → demyelination and secondary axonal loss	No disease-modifying therapy; supportive care, orthotics, physical therapy
Chronic Inflammatory Demyelinating Polyneuropathy	Chronic autoimmune attack on peripheral nerve myelin — similar mechanism to Guillain-Barré syndrome but ongoing	Responds to immunomodulation: intravenous immunoglobulin, corticosteroids, or plasmapheresis

Neuromuscular Junction Pathology

The neuromuscular junction is where nerve meets muscle — a highly specialized synapse designed for reliable, rapid transmission. Disorders here produce the characteristic feature of fatigable weakness.

Condition	Site of Defect	Mechanism	Clinical Features
Juvenile Myasthenia Gravis	Postsynaptic (acetylcholine receptor)	Autoantibodies bind to acetylcholine receptors → receptor internalization and complement-mediated damage → reduced receptor density	Fatigable weakness, ptosis worse by evening, diplopia, bulbar weakness; improves with rest; positive response to acetylcholinesterase inhibitors
Congenital Myasthenic Syndromes	Variable (presynaptic, synaptic, or postsynaptic)	Genetic mutations affecting proteins involved in neuromuscular transmission — varies by syndrome	Early onset, often presents in infancy with feeding difficulties, ptosis, weakness; may be episodic; treatment depends on specific defect
Botulism	Presynaptic	Botulinum toxin cleaves SNARE proteins required for acetylcholine vesicle release → blocked neuromuscular transmission	Descending paralysis, bulbar symptoms prominent, dilated pupils, constipation, autonomic dysfunction; infant botulism presents with hypotonia and poor feeding
Tick Paralysis	Presynaptic	Toxin from tick saliva blocks acetylcholine release at nerve terminal	Ascending paralysis mimicking Guillain-Barré syndrome; resolves rapidly with tick removal — always search for attached tick!

Why Weakness is Fatigable in Neuromuscular Junction Disorders

At the normal neuromuscular junction, each nerve action potential releases far more acetylcholine than needed to trigger muscle contraction — a “safety factor.” With repeated stimulation, acetylcholine stores temporarily deplete but remain above threshold. In myasthenia gravis, the reduced number of functioning receptors eliminates this safety margin. With repeated stimulation:

Acetylcholine release decreases (normal physiology)
Fewer receptors are available to respond (disease effect)
Eventually, signal falls below threshold for muscle contraction
Result: Progressive weakness with continued activity (fatigability)

This explains why symptoms worsen throughout the day and improve with rest.

Muscle (Myopathy) Pathology

Myopathies involve primary dysfunction of the muscle fiber itself. Understanding the structural components of muscle helps explain different disease mechanisms.

Dystrophin-Related

Normal function: Dystrophin links intracellular actin to the extracellular matrix, stabilizing the sarcolemma during contraction.

When absent (Duchenne muscular dystrophy): Sarcolemma tears during contraction → calcium influx → fiber necrosis → replacement by fat and fibrosis.

Clinical correlation: Progressive proximal weakness, calf pseudohypertrophy, massively elevated creatine kinase.

Inflammatory

Mechanism: Autoimmune attack on muscle — different targets in different conditions.

Dermatomyositis: Complement-mediated attack on endothelial cells → perifascicular atrophy.

Polymyositis: CD8+ T-cell attack on muscle fibers.

Clinical correlation: Proximal weakness, may have skin findings, responds to immunosuppression.

Metabolic

Mechanism: Defects in energy production pathways.

Glycogen storage disorders: Cannot access glycogen for energy (Pompe disease — acid maltase deficiency).

Fatty acid oxidation defects: Cannot use fat for energy during fasting or prolonged exercise.

Clinical correlation: May have episodic weakness, exercise intolerance, or cardiac involvement.

Myopathy Type	Example	Mechanism	Treatment Implication
Muscular Dystrophy	Duchenne muscular dystrophy	Absence of dystrophin → sarcolemma instability → progressive muscle fiber necrosis	Corticosteroids slow progression; exon-skipping and gene therapy emerging; supportive care (respiratory, cardiac, orthopedic)
Congenital Myopathy	Central core disease, nemaline myopathy	Structural abnormalities of sarcomere or sarcoplasmic reticulum — often calcium handling defects	Supportive care; some at risk for malignant hyperthermia — avoid triggering anesthetics
Metabolic Myopathy	Pompe disease (glycogen storage disease type II)	Deficiency of acid alpha-glucosidase → glycogen accumulation in lysosomes → muscle fiber damage	Enzyme replacement therapy (alglucosidase alfa) — early treatment before irreversible damage critical
Inflammatory Myopathy	Juvenile dermatomyositis	Autoimmune vasculopathy → complement-mediated endothelial damage → muscle ischemia and inflammation	Responds to immunosuppression (corticosteroids, methotrexate, intravenous immunoglobulin)
Ion Channel Myopathy	Hypokalemic periodic paralysis	Mutations in calcium or sodium channels → abnormal membrane excitability → episodes of paralysis triggered by low potassium	Avoid triggers (carbohydrate loads, rest after exercise); potassium supplementation; acetazolamide prophylaxis

Developmental Considerations in Pediatric Weakness

The developing nervous system and muscle have unique vulnerabilities and response patterns that differ from adults.

Why Children Present Differently

Myelination is incomplete:

Corticospinal tract myelination continues until age 2
Upper motor neuron signs may be subtle or absent in infants
Babinski reflex is normal until 12-18 months

Motor unit is immature:

Muscle fiber type differentiation ongoing
Congenital conditions may present with hypotonia rather than weakness
Reserve capacity is limited — decompensation rapid

Complications of Weakness Itself

Regardless of the underlying cause, weakness leads to secondary complications that require proactive management.

System	Complication	Mechanism	Prevention/Management
Respiratory	Hypoventilation, atelectasis, recurrent infections, respiratory failure	Inspiratory and expiratory muscle weakness → reduced vital capacity and cough strength	Monitor forced vital capacity; cough assist devices; nocturnal non-invasive ventilation when needed
Musculoskeletal	Contractures, scoliosis, hip dysplasia, osteoporosis	Muscle imbalance and reduced weight-bearing	Physical therapy, stretching, orthoses, standing frames; surgical intervention when indicated
Cardiac	Cardiomyopathy, arrhythmias	Some myopathies directly affect cardiac muscle (Duchenne muscular dystrophy, Pompe disease)	Regular echocardiography; cardioprotective medications (angiotensin-converting enzyme inhibitors, beta-blockers)
Nutritional	Failure to thrive, obesity, dysphagia	Increased energy expenditure (inefficient movement) or decreased (immobility); bulbar weakness	Dietitian involvement; modified textures; gastrostomy when needed

Key Pathophysiology Principles:

Localization determines investigation: Upper motor neuron → brain/spine imaging; lower motor neuron → electrodiagnostics and muscle studies
Mechanism determines treatment: Inflammatory → immunotherapy; genetic → supportive care and emerging gene therapies
Tempo suggests etiology: Acute → inflammatory, infectious, vascular; chronic → genetic, degenerative
Pattern provides clues: Proximal → myopathy; distal → neuropathy; fatigable → neuromuscular junction

3. History Taking

A comprehensive approach to eliciting the weakness history in children

Red Flags — Require Urgent Evaluation

Respiratory distress or weak cry — Impending respiratory failure
Rapidly ascending weakness — Guillain-Barré syndrome, transverse myelitis
Bulbar symptoms (dysphagia, dysarthria, drooling) — Aspiration risk, brainstem involvement
Acute onset with altered consciousness — Stroke, encephalitis, spinal cord compression
Bladder or bowel dysfunction — Spinal cord pathology (cauda equina, transverse myelitis)
Neck stiffness with weakness — Meningitis, spinal cord compression

Recent trauma with weakness — Spinal cord injury, epidural hematoma
Fever with acute paralysis — Acute flaccid myelitis, poliomyelitis, transverse myelitis
Ptosis with dilated pupils — Botulism (especially in infants)
Weakness after honey ingestion (infant) — Infant botulism
Tick exposure with ascending weakness — Tick paralysis (reversible with tick removal)
Motor regression or loss of milestones — Neurodegenerative disease, spinal muscular atrophy

History taking in pediatric weakness requires careful attention to the child’s developmental stage, the caregiver’s observations, and age-specific presentations. Parents are often the first to notice subtle changes — “something is not right” — even before objective weakness is apparent. The history should systematically address onset, progression, distribution, and associated features while remaining alert to red flags requiring urgent intervention.

Systematic History: The “WEAKNESS” Approach

Use the mnemonic “WEAKNESS” to ensure comprehensive history taking:

W — When and How: When did weakness start? Was onset sudden (minutes-hours), acute (days), subacute (weeks), or chronic (months)? Was there a precipitating event?
E — Evolution and Pattern: Is it getting worse, stable, or fluctuating? Is it constant or episodic? Does it vary throughout the day?
A — Anatomical Distribution: Which muscles are affected? Proximal or distal? Symmetric or asymmetric? Face and swallowing involved?
K — Key Associated Symptoms: Sensory changes? Pain? Fatigue? Breathing difficulty? Swallowing problems? Bowel/bladder changes?
N — Neurological and Developmental History: Milestones achieved? Any regression? Previous similar episodes? Birth history?
E — Exposures and Triggers: Recent infections? Vaccinations? Tick bites? Medications? Toxins? Exercise or fasting triggers?
S — System Review and Family History: Cardiac, respiratory, or other organ involvement? Family history of neuromuscular disease?
S — Social and Functional Impact: How is this affecting daily life? School attendance? Mobility? Independence?

Characterizing the Weakness

Onset and Tempo

Tempo	Key Questions	Diagnostic Implications
Hyperacute (minutes to hours)	“Was there a specific moment when the weakness started? What was the child doing? Any trauma or fall? Any preceding headache or altered consciousness?”	Stroke, spinal cord compression, trauma, periodic paralysis, tick paralysis
Acute (hours to days)	“Did the weakness develop over hours or days? Did it start in one area and spread? Any recent illness — cold, diarrhea, stomach bug?”	Guillain-Barré syndrome, transverse myelitis, acute flaccid myelitis, viral myositis, botulism
Subacute (days to weeks)	“Has the weakness been gradually worsening over the past few weeks? Any associated rash, joint pain, or other symptoms?”	Inflammatory myopathy, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, tumor
Chronic (weeks to months)	“When did you first notice something was different? Look back at photos/videos — was there a change? Has the child stopped doing things they used to do?”	Muscular dystrophy, spinal muscular atrophy, congenital myopathy, hereditary neuropathy
Episodic	“Does the weakness come and go? How long do episodes last? What triggers them? Is the child completely normal between episodes?”	Periodic paralysis, metabolic myopathy, myasthenia gravis, mitochondrial disease

Distribution and Pattern

Pattern	Key Questions	What This Suggests
Proximal weakness	“Does your child have trouble climbing stairs, getting up from the floor, or raising arms to wash hair? Do they use their hands to push up from sitting (Gowers maneuver)?”	Myopathy — muscular dystrophy, inflammatory myopathy, metabolic myopathy
Distal weakness	“Does your child trip over their feet or have trouble with buttons, zippers, or holding a pencil? Do shoes wear out unevenly?”	Neuropathy — Charcot-Marie-Tooth disease, distal myopathy
Ascending weakness	“Did the weakness start in the legs and then spread to the arms? Is it getting higher over hours to days?”	Guillain-Barré syndrome, tick paralysis
Descending weakness	“Did problems with the eyes, face, or swallowing start before the limb weakness?”	Botulism, myasthenia gravis (ocular onset)
Asymmetric/Focal	“Is one side or one limb affected more than the other? Was there any injury or recent immunization in that limb?”	Stroke, acute flaccid myelitis, brachial plexus injury, mononeuropathy
Fatigable	“Is the weakness worse at the end of the day or after activity? Does rest help? Is the droopy eyelid worse by evening?”	Myasthenia gravis, congenital myasthenic syndrome

Key Questions by Suspected Etiology

Suspected Cause	Key Features	Ask This Question
Guillain-Barré Syndrome	Ascending weakness, areflexia, preceding infection 1-4 weeks prior	“Did your child have a cold, stomach bug, or diarrhea in the past few weeks? Did the weakness start in the legs and move up? Any tingling in the hands or feet?”
Duchenne Muscular Dystrophy	Progressive proximal weakness in boys, calf enlargement, Gowers sign, elevated creatine kinase	“Does your son have trouble keeping up with other children? Does he use his hands to climb up his legs when getting up from the floor? Have you noticed his calves look bigger than expected?”
Spinal Muscular Atrophy	Symmetric proximal weakness, hypotonia, tongue fasciculations, preserved cognition	“Has your baby always been floppy? Do you notice the tongue twitching when the mouth is at rest? Is your baby meeting developmental milestones? Any family members with similar problems or early infant deaths?”
Myasthenia Gravis	Fatigable weakness, ptosis, diplopia, bulbar symptoms, fluctuating course	“Is the droopy eyelid worse in the evening? Does your child see double when tired? Is swallowing or speech worse after eating? Do symptoms improve after rest?”
Juvenile Dermatomyositis	Proximal weakness with characteristic rash (heliotrope, Gottron papules)	“Has your child developed any rash — especially around the eyes or on the knuckles? Is there muscle pain along with the weakness? Any difficulty swallowing?”
Botulism	Descending paralysis, bulbar symptoms, autonomic dysfunction, constipation	“Has your baby been constipated? Have they had honey or corn syrup? Is the cry weak? Are they having trouble feeding? Are the pupils large and not responding to light?”
Acute Flaccid Myelitis	Acute limb weakness, often asymmetric, preceding respiratory illness, MRI shows cord changes	“Did your child have a respiratory illness before the weakness started? Is the weakness affecting one limb more than others? Any neck pain or back pain?”
Periodic Paralysis	Episodic weakness with full recovery, triggered by carbohydrates, exercise, or cold	“Does the weakness come in episodes with normal strength between? What triggers it — eating a big meal, resting after exercise, being cold? Does anyone else in the family have similar episodes?”
Tick Paralysis	Ascending paralysis, recent outdoor exposure, rapid resolution with tick removal	“Has your child been outdoors in wooded areas recently? Have you checked thoroughly for ticks — including the scalp and behind the ears?”

Pediatric-Specific History Components

Birth and Perinatal History

Pregnancy complications: Polyhydramnios (suggests fetal weakness with poor swallowing), decreased fetal movements
Delivery: Gestational age, birth weight, presentation (breech more common with hypotonia), mode of delivery
Neonatal period: Hypotonia, feeding difficulties, respiratory support, NICU admission, arthrogryposis (joint contractures from lack of movement in utero)
Apgar scores: Low scores may indicate perinatal hypoxia or congenital neuromuscular disease

Developmental History

Motor milestones: Head control (3-4 months), rolling (4-6 months), sitting (6-8 months), crawling (8-10 months), walking (12-18 months)
Quality of movement: Was walking always abnormal? W-sitting? Toe-walking?
Regression: Loss of previously acquired skills is always concerning
Cognitive development: Language, social skills — often preserved in neuromuscular disease, affected in central disorders

Family History

Neuromuscular disease: Anyone with muscle weakness, difficulty walking, wheelchair use?
Early deaths: Infant deaths, respiratory failure in young adults (may suggest undiagnosed neuromuscular disease)
Consanguinity: Increases risk of autosomal recessive conditions (spinal muscular atrophy, congenital myopathies)
Pattern of inheritance: Affected males only (X-linked: Duchenne), both sexes (autosomal)
Maternal history: Myasthenia gravis can cause transient neonatal weakness; myotonic dystrophy is more severe with maternal inheritance

Feeding History

Breastfeeding: Weak suck, fatigue during feeds, prolonged feeding times
Bottle feeding: Special nipples needed? Formula dribbling from mouth?
Swallowing: Coughing or choking with feeds (aspiration risk)
Weight gain: Poor weight gain may indicate chronic feeding difficulty
Texture progression: Difficulty with solids may indicate bulbar weakness

Exposures and Triggers

Exposure/Trigger	Questions to Ask	Associated Conditions
Recent infection	“Any illness in the past 1-4 weeks? Respiratory infection? Gastroenteritis? Campylobacter?”	Guillain-Barré syndrome (especially after Campylobacter), acute flaccid myelitis (enterovirus), transverse myelitis
Vaccination	“Any vaccinations in the past few weeks?”	Very rare association with Guillain-Barré syndrome (risk much lower than infection-related risk)
Tick exposure	“Any outdoor activities? Camping, hiking? Check scalp, hairline, behind ears, groin”	Tick paralysis — fully reversible with tick removal
Honey or soil (infant)	“Has your baby had honey, corn syrup, or been exposed to soil or dust?”	Infant botulism
Exercise	“Does weakness occur during or after exercise? Any muscle cramps or dark urine?”	Metabolic myopathy (McArdle disease), rhabdomyolysis, periodic paralysis (post-exercise)
Fasting	“Does weakness occur after not eating for a while? After illness when not eating well?”	Fatty acid oxidation defects, glycogen storage disorders
Carbohydrate load	“Does weakness occur after eating a big meal, especially with lots of carbohydrates?”	Hypokalemic periodic paralysis
Cold exposure	“Does cold weather or cold water trigger weakness or stiffness?”	Paramyotonia congenita, hyperkalemic periodic paralysis

Medication and Toxin History

Medications That Can Cause Weakness

Corticosteroids (chronic use): Steroid myopathy — proximal weakness
Aminoglycosides: Can unmask or worsen myasthenia gravis
Statins: Rare in children but can cause myopathy
Chemotherapy agents: Vincristine causes peripheral neuropathy
Antiretrovirals: Mitochondrial myopathy with older agents
Colchicine: Myoneuropathy with chronic use

Toxin Exposures

Lead: Motor neuropathy (wrist drop, foot drop)
Organophosphates: Cholinergic crisis then weakness
Botulinum toxin: Food-borne or wound botulism
Tetrodotoxin: Pufferfish poisoning
Heavy metals: Arsenic, thallium — peripheral neuropathy
Alcohol: Adolescents — acute and chronic myopathy

Associated Symptoms to Explore

Symptom	Questions	Significance
Pain	“Is there muscle pain or tenderness? Back pain? Limb pain?”	Inflammatory myopathy (muscle pain), Guillain-Barré syndrome (limb/back pain common), transverse myelitis (back pain)
Sensory symptoms	“Any numbness, tingling, or unusual sensations? Difficulty feeling temperature?”	Suggests neuropathy or spinal cord involvement; absent in pure myopathy or neuromuscular junction disease
Respiratory symptoms	“Any breathing difficulty? Shortness of breath when lying flat? Weak cough? Frequent chest infections?”	Diaphragm weakness — may be presenting feature of spinal muscular atrophy, Pompe disease, or progression in Guillain-Barré syndrome
Autonomic symptoms	“Any constipation? Difficulty urinating? Dizziness on standing? Abnormal sweating?”	Botulism (constipation, dilated pupils), Guillain-Barré syndrome (blood pressure and heart rate instability)
Cognitive or behavioral changes	“Any changes in thinking, memory, or behavior? Seizures?”	Suggests central nervous system involvement; cognitive impairment seen in some muscular dystrophies
Rash	“Any skin changes — rash around the eyes, on the knuckles, or elsewhere?”	Dermatomyositis — heliotrope rash (purple discoloration around eyes), Gottron papules (scaly rash over knuckles)

History-Taking Pearls

Review photos and videos: Parents often have photos showing calf enlargement, posture changes, or Gowers sign before they recognized weakness
Ask about what the child CAN’T do anymore: “What could they do 6 months ago that they can’t do now?”
Trust parental concern: “My child seems weaker” from a parent is often correct even when examination is initially normal
Compare to siblings: “Is this child keeping up with siblings at the same age?”
School performance: Physical education reports may document declining athletic ability
Search for the tick: In any child with acute ascending weakness — check the entire body including scalp

4. Physical Examination

A systematic approach to examining the weak child

Examination Framework: The neurological examination of the weak child should be systematic, age-appropriate, and integrated with general physical examination. Much can be learned from observation before any formal testing. The key questions are: (1) Is there true weakness? (2) Where is the lesion — upper motor neuron, lower motor neuron, neuromuscular junction, or muscle? (3) What is the pattern — proximal, distal, symmetric, focal?

General Inspection — Before You Touch

Observation begins the moment the child enters the room. Much of the motor examination can be completed through careful observation of spontaneous activity.

Observe	What to Look For	Clinical Significance
Posture	Frog-leg position, head lag, hyperlordosis, kyphosis, scoliosis	Frog-leg suggests hypotonia; hyperlordosis suggests pelvic girdle weakness; scoliosis may indicate asymmetric weakness
Spontaneous movement	Quantity and quality of movement, asymmetry, antigravity movement	Reduced movement suggests weakness; preserved antigravity movement with hypotonia suggests central cause
Face	Ptosis, facial asymmetry, expressionless face, open mouth, tented upper lip	Ptosis suggests myasthenia or mitochondrial disease; myopathic facies (long, expressionless) in congenital myopathies; tented lip in myotubular myopathy
Muscle bulk	Atrophy (wasting), pseudohypertrophy (especially calves), asymmetry	Atrophy suggests denervation or disuse; calf pseudohypertrophy classic for Duchenne muscular dystrophy
Fasciculations	Visible twitching of muscle at rest, especially tongue	Suggests anterior horn cell disease — look at tongue in spinal muscular atrophy
Skin	Heliotrope rash, Gottron papules, café-au-lait spots, contractures	Dermatomyositis rash; neurofibromatosis (rarely causes weakness); contractures suggest chronic process
Breathing pattern	Paradoxical breathing (chest retracts while abdomen expands), use of accessory muscles, weak cough	Paradoxical breathing indicates diaphragm weakness — concerning for respiratory failure

Vital Signs — Age-Appropriate Values

Age	Heart Rate (bpm)	Respiratory Rate (/min)	Systolic BP (mmHg)	Key Concerns in Weakness
Neonate (0-28 days)	100-160	30-60	60-90	Tachypnea may be only sign of respiratory muscle weakness
Infant (1-12 months)	100-150	25-40	80-100	Monitor for feeding-related desaturations
Toddler (1-3 years)	90-140	20-30	90-105	Tachycardia may compensate for reduced stroke volume
School age (4-12 years)	70-120	18-25	95-110	Orthostatic hypotension in autonomic dysfunction (Guillain-Barré syndrome)
Adolescent (13-18 years)	60-100	12-20	100-120	Can measure forced vital capacity; autonomic instability

Respiratory Assessment — Critical in Neuromuscular Disease

Paradoxical breathing: Abdomen rises while chest falls during inspiration — indicates diaphragm weakness
Accessory muscle use: Nasal flaring, intercostal retractions, neck muscle activation
Weak cough: Ask child to cough — a weak, ineffective cough indicates expiratory muscle weakness and inability to clear secretions
Orthopnea: In older children, difficulty breathing when lying flat
Count test: Ask child to count to 20 in one breath — reduced count indicates reduced vital capacity
Forced vital capacity: If possible, measure with bedside spirometry — less than 20 mL/kg is concerning; less than 15 mL/kg may need ventilatory support

Neurological Examination

Tone Assessment

Technique	How to Perform	Findings
Vertical suspension (infant)	Hold infant under arms and lift — observe for “slip through” (sliding down through hands)	Hypotonic infant slips through; normal infant can be held securely
Horizontal suspension (infant)	Hold infant prone, supported under chest — observe head and limb position	Hypotonic infant drapes like an “inverted U”; normal infant holds head up and limbs somewhat flexed
Pull to sit (infant)	Pull infant from supine to sitting by hands — observe head lag	Significant head lag after 4 months is abnormal; complete head lag at any age suggests severe hypotonia
Scarf sign	Pull arm across chest toward opposite shoulder — observe how far elbow crosses midline	Elbow crossing past midline easily suggests hypotonia
Passive range of motion	Flex and extend limbs passively, noting resistance	Reduced resistance = hypotonia (lower motor neuron); increased resistance = hypertonia (upper motor neuron — spasticity or rigidity)
Popliteal angle	Flex hip to 90°, extend knee — measure angle when resistance felt	Large angle (greater than 90°) suggests hypotonia; small angle suggests spasticity

Strength Testing

Formal Medical Research Council (MRC) grading can be used in cooperative children (typically over age 5). For younger children, strength must be assessed through observation and functional tasks.

MRC Grade	Description	Functional Equivalent in Children
5 — Normal	Full strength against full resistance	Can perform all age-appropriate activities without difficulty
4 — Good	Movement against gravity and some resistance	Can walk, run, climb stairs but fatigues or struggles with heavy resistance
3 — Fair	Movement against gravity only, no added resistance	Can lift limb off bed but cannot resist examiner’s push; can walk on flat but struggles with stairs
2 — Poor	Movement with gravity eliminated	Can slide limb along bed but cannot lift it; cannot walk independently
1 — Trace	Visible muscle contraction but no movement	Can see or feel muscle twitch but no useful movement
0 — None	No visible contraction	Complete paralysis of that muscle group

Functional Strength Assessment by Age

Age Group	Assessment Method	What to Look For
Infant	Observe spontaneous movement, antigravity limb movements, head control, pull to sit, rolling	Does the baby kick legs up off the bed? Lift arms against gravity? Move all four limbs equally?
Toddler	Observe walking, running, climbing, getting up from floor (Gowers sign), stair climbing	Does the child use hands to push up from floor? Climb stairs one at a time with rail? Fall frequently?
School age	Formal MRC testing plus functional tasks: heel and toe walking, single leg hop, rising from squat, step-ups	Can the child hop on each leg? Rise from squatting without using hands? Walk on heels (tests ankle dorsiflexion)?
Adolescent	Full MRC testing, timed functional tests (10-meter walk, rise from floor time)	Quantitative measures allow tracking of progression or response to treatment

Key Functional Tests

Gowers Sign:

Ask child to lie on floor and get up
Positive: Child “walks” hands up thighs to push body upright
Indicates proximal (hip girdle) weakness
Classic for Duchenne muscular dystrophy but non-specific

Heel and Toe Walking:

Heel walking tests ankle dorsiflexors (L4-L5)
Toe walking tests plantar flexors (S1-S2)
Difficulty with heel walking seen early in Charcot-Marie-Tooth disease
Habitual toe walking may indicate tight heel cords (Duchenne muscular dystrophy)

Deep Tendon Reflexes

Reflex	Nerve Root	Technique	Interpretation
Biceps	C5-C6	Strike biceps tendon with elbow flexed	Hyperreflexia (3+ or 4+): Upper motor neuron lesion Hyporeflexia or areflexia (1+ or 0): Lower motor neuron lesion (anterior horn cell, nerve, or severe myopathy) Normal reflexes with weakness: Myopathy or neuromuscular junction disorder (early)
Triceps	C6-C7	Strike triceps tendon above elbow with arm relaxed
Brachioradialis	C5-C6	Strike radius just above wrist
Patellar (knee)	L3-L4	Strike patellar tendon with knee relaxed (dangling or supported)
Achilles (ankle)	S1-S2	Strike Achilles tendon with foot dorsiflexed

Plantar Response (Babinski Sign)

Technique: Stroke lateral sole from heel toward toes with blunt object
Normal response: Plantar flexion of toes (toes curl down)
Abnormal (positive Babinski): Extension of great toe with fanning of other toes
Interpretation: Positive Babinski indicates upper motor neuron lesion; however, upgoing toes are NORMAL in infants under 12-18 months due to incomplete myelination

Sensory Examination

Sensory examination is challenging in young children but important to localize lesions. Pure myopathies and neuromuscular junction disorders have NO sensory involvement.

Modality	Tests	Pattern Suggesting Neuropathy
Light touch	Cotton wisp; ask “Where am I touching you?”	Glove-and-stocking distribution (distal more than proximal) suggests length-dependent neuropathy
Pin prick	Sharp object (use caution); compare proximal versus distal, left versus right
Vibration	Tuning fork (128 Hz) on bony prominences	Loss of vibration at ankle before knee suggests peripheral neuropathy
Proprioception	Move toe or finger up/down with eyes closed; ask direction	Loss of proprioception suggests dorsal column or large fiber sensory neuropathy

Cranial Nerve Examination Relevant to Weakness

Cranial Nerve	Test	Abnormality and Significance
II, III — Pupils	Pupil size, reactivity to light	Dilated, poorly reactive pupils: botulism; ptosis with normal pupils: myasthenia
III, IV, VI — Eye movements	Follow finger in H pattern; observe for ptosis	Ptosis (III); diplopia and strabismus: myasthenia, botulism, Miller Fisher syndrome
V — Trigeminal	Jaw opening against resistance; facial sensation	Jaw weakness in myasthenia gravis; sensory loss in brainstem lesions
VII — Facial	Raise eyebrows, close eyes tight, smile, puff cheeks	Facial weakness: myopathies (cannot bury eyelashes), facioscapulohumeral muscular dystrophy
IX, X — Swallowing	Say “ah” — observe palate elevation; gag reflex; watch swallow	Bulbar weakness: nasal speech, palatal weakness, pooling secretions — aspiration risk
XI — Accessory	Shoulder shrug, head turn against resistance	Weakness of sternocleidomastoid and trapezius
XII — Hypoglossal	Tongue protrusion, look for atrophy or fasciculations	Tongue fasciculations classic in spinal muscular atrophy; atrophy in motor neuron disease

Special Tests

Fatigability Testing

For suspected myasthenia gravis:

Sustained upgaze: Ask child to look up at ceiling for 60-120 seconds — watch for increasing ptosis
Repeated movements: Ask child to open and close fist repeatedly — observe for weakening grip
Ice pack test: Apply ice to closed eyelid for 2 minutes — improvement in ptosis suggests myasthenia (cold improves neuromuscular transmission)
Simpson test: Sustained upgaze causing ptosis and lid fatigue

Myotonia Testing

For suspected myotonic disorders:

Grip myotonia: Ask child to make tight fist then open quickly — delayed relaxation indicates myotonia
Percussion myotonia: Tap thenar eminence with reflex hammer — sustained contraction with slow relaxation
Lid lag: Ask child to look down quickly after looking up — upper lid lags behind

Growth and Developmental Assessment

Parameter	How to Assess	Significance in Weakness
Weight	Plot on growth chart; calculate percentile and z-score	Poor weight gain may indicate chronic feeding difficulty; obesity common in wheelchair-dependent children
Height/Length	Supine length under 2 years; standing height over 2 years	Short stature may indicate chronic illness; contractures affect accurate measurement
Head circumference	Measure and plot (especially in children under 3 years)	Macrocephaly in some congenital myopathies; microcephaly suggests central nervous system involvement
Motor milestones	Compare to expected ages: head control (3-4 months), sitting (6-8 months), walking (12-18 months)	Delayed milestones suggest chronic process; loss of milestones (regression) is alarming

Musculoskeletal Examination

Spine: Scoliosis (asymmetric weakness), hyperlordosis (pelvic weakness), kyphosis
Joints: Contractures (hip flexion, knee flexion, ankle plantar flexion — Achilles tendon tightness), hypermobility
Feet: Pes cavus (high arches) and hammer toes suggest chronic neuropathy (Charcot-Marie-Tooth); flat feet common in hypotonia
Hips: Check range of motion; hip dysplasia may develop in hypotonic infants

Cardiac Examination

Essential in suspected muscular dystrophy, mitochondrial disease, and Pompe disease.

Heart rate and rhythm: Arrhythmias in muscular dystrophies, mitochondrial disease
Heart sounds: Murmurs may indicate cardiomyopathy
Signs of heart failure: Hepatomegaly, edema, raised jugular venous pressure (in older children)
Cardiomegaly: May be detected clinically or on chest X-ray; prominent in Pompe disease

Expected Findings by Etiology

Condition	Tone	Reflexes	Distribution	Other Key Findings
Upper Motor Neuron Lesion	Increased (spastic)	Hyperreflexia, clonus, positive Babinski	Pyramidal pattern	May be initially flaccid (spinal shock); no atrophy early
Spinal Muscular Atrophy	Decreased (flaccid)	Absent or markedly reduced	Proximal more than distal; legs more than arms	Tongue fasciculations; alert, bright expression; paradoxical breathing
Guillain-Barré Syndrome	Decreased (flaccid)	Absent (areflexia is hallmark)	Ascending, symmetric	Sensory symptoms; facial weakness; autonomic dysfunction
Duchenne Muscular Dystrophy	Normal early; decreased late	Present early; reduced late	Proximal; pelvic more than shoulder	Calf pseudohypertrophy; Gowers sign; lordosis; toe walking
Myasthenia Gravis	Normal	Normal	Ocular and bulbar; limb weakness variable	Fatigable ptosis; diplopia; weakness worse with activity and later in day
Dermatomyositis	Normal or slightly decreased	Normal or slightly reduced	Proximal; symmetric	Heliotrope rash; Gottron papules; nail fold capillary changes
Charcot-Marie-Tooth Disease	Normal or decreased	Reduced or absent (especially ankle)	Distal; length-dependent	Pes cavus; hammer toes; “stork leg” appearance; sensory loss
Botulism	Decreased (flaccid)	Reduced or absent	Descending; bulbar prominent	Dilated pupils; constipation; weak cry; poor feeding (infants)
Congenital Myopathy	Decreased (hypotonia)	Reduced	Generalized; often proximal predominant	Myopathic facies; high-arched palate; may have respiratory involvement

Important Teaching Point

The examination may be normal or near-normal in several important conditions:

Early myasthenia gravis: Between episodes, strength and reflexes may be completely normal — fatigability testing is key
Early Duchenne muscular dystrophy: A 2-year-old with delayed walking may have subtle findings only; elevated creatine kinase often detected before examination is clearly abnormal
Periodic paralysis: Between episodes, examination is entirely normal
Metabolic myopathy: May only manifest during metabolic stress (fasting, illness, exercise)

A normal examination does not exclude significant neuromuscular disease — clinical suspicion based on history should drive investigation.

Examination Pearls

Always examine the tongue: Fasciculations are easily missed but highly specific for anterior horn cell disease
Always check for a tick: In any child with acute ascending weakness — search scalp, behind ears, hairline, groin
Test fatigability: If myasthenia is suspected, weakness may only appear after sustained activity
Observe before testing: Watch the child play, walk, climb onto the examination table — more information than formal testing in young children
Assess respiratory function: In acute weakness, this takes priority — paradoxical breathing is a warning sign
Compare sides: Subtle asymmetry may be the first clue to focal pathology

5. Differential Diagnosis

Systematic approach organized by probability, tempo, and anatomical localization

The differential diagnosis of weakness in children is broad, spanning from benign self-limiting conditions to life-threatening emergencies and progressive genetic disorders. A systematic approach based on tempo of onset, anatomical localization, and pattern of weakness allows efficient narrowing of possibilities. Always consider treatable and time-sensitive conditions first.

Acute Weakness (Hours to Days)

Acute weakness demands urgent evaluation. The primary concern is identifying conditions requiring immediate intervention to prevent permanent neurological damage or death.

Probability	Condition	Key Features	Red Flags / Urgency
COMMON	Guillain-Barré Syndrome	Ascending symmetric weakness, areflexia, preceding infection 1-4 weeks prior (respiratory or gastrointestinal), sensory symptoms, back/limb pain	Respiratory failure risk — monitor vital capacity; autonomic instability; bulbar weakness with aspiration risk
COMMON	Acute Viral Myositis	Calf pain and tenderness, difficulty walking, follows influenza or other viral illness, elevated creatine kinase, self-limiting	Usually benign; rarely progresses to rhabdomyolysis — check for dark urine, acute kidney injury
COMMON	Post-Infectious Cerebellar Ataxia	Ataxia more than weakness, post-viral, self-limiting; may be misinterpreted as weakness	Distinguish from more serious posterior fossa pathology
LESS COMMON	Transverse Myelitis	Bilateral weakness (may be asymmetric), sensory level, bladder/bowel dysfunction, back pain, rapid progression over hours to days	MRI spine urgently; may be first presentation of multiple sclerosis, neuromyelitis optica, or acute disseminated encephalomyelitis
LESS COMMON	Acute Flaccid Myelitis	Acute limb weakness often asymmetric, preceding respiratory illness (enterovirus D68/A71), MRI shows gray matter changes in cord	Seasonal (late summer/fall); variable recovery; no proven treatment — supportive care
LESS COMMON	Myasthenic Crisis	Acute worsening in known myasthenia gravis, often triggered by infection; respiratory and bulbar weakness	Respiratory failure imminent — ICU admission; differentiate from cholinergic crisis
UNCOMMON BUT SERIOUS	Botulism	Descending paralysis, bulbar onset, dilated pupils, constipation, autonomic dysfunction; infant: hypotonia, weak cry, poor feeding, honey exposure	Respiratory failure; antitoxin needed urgently (food-borne); supportive care for infant botulism
UNCOMMON BUT SERIOUS	Tick Paralysis	Ascending paralysis mimicking Guillain-Barré syndrome, ataxia, no sensory changes, recent outdoor exposure	Completely reversible with tick removal — search entire body including scalp!
UNCOMMON BUT SERIOUS	Spinal Cord Compression	Back pain, weakness below level of lesion, sensory level, bladder/bowel dysfunction; causes: tumor, abscess, hematoma, disc herniation	Neurosurgical emergency — MRI spine immediately; steroids if tumor suspected
UNCOMMON BUT SERIOUS	Pediatric Stroke	Sudden onset hemiparesis, facial weakness, speech changes; risk factors: cardiac disease, sickle cell, moyamoya, arterial dissection	Time-sensitive — consider thrombolysis/thrombectomy in appropriate cases; urgent neuroimaging
UNCOMMON BUT SERIOUS	Periodic Paralysis	Episodes of flaccid weakness, may be triggered by carbohydrates (hypokalemic) or cold/rest after exercise (hyperkalemic), family history	Check potassium urgently — severe hypokalemia or hyperkalemia can cause cardiac arrhythmias

Subacute Weakness (Days to Weeks)

Subacute onset suggests inflammatory, autoimmune, or neoplastic processes. Many of these conditions are treatable if identified promptly.

Probability	Condition	Key Features	Expected Course
COMMON	Juvenile Dermatomyositis	Proximal weakness, characteristic rash (heliotrope eyelids, Gottron papules over knuckles), muscle pain, elevated creatine kinase and aldolase	Responds to immunosuppression; may have calcinosis, gastrointestinal vasculopathy as complications
COMMON	Juvenile Myasthenia Gravis (New Onset)	Fatigable weakness, ptosis, diplopia, bulbar symptoms; may present subacutely with gradual worsening	Treatable with acetylcholinesterase inhibitors, immunotherapy; variable course
LESS COMMON	Chronic Inflammatory Demyelinating Polyneuropathy	Progressive symmetric weakness over more than 8 weeks, proximal and distal, areflexia, sensory involvement, elevated cerebrospinal fluid protein	Responds to intravenous immunoglobulin, corticosteroids, or plasmapheresis; relapsing course common
LESS COMMON	Spinal Cord Tumor	Progressive weakness, back pain (often nocturnal, worse lying down), sensory level, scoliosis, bladder/bowel changes	Requires neurosurgical evaluation; prognosis depends on tumor type and resectability
LESS COMMON	Brain Tumor (Motor Cortex)	Progressive hemiparesis, headache, seizures, personality changes; upper motor neuron signs	Imaging essential; treatment depends on tumor type
UNCOMMON	Juvenile Polymyositis	Similar to dermatomyositis but without rash; proximal weakness, elevated muscle enzymes	Less common than dermatomyositis in children; responds to immunosuppression

Chronic Weakness (Weeks to Months to Years)

Chronic weakness in children most often reflects genetic neuromuscular disorders. Early diagnosis enables genetic counseling, anticipatory management, and access to emerging disease-modifying therapies.

Step-by-Step Approach to Chronic Weakness:

Step 1: Localize the lesion — Is this upper motor neuron (spastic, hyperreflexic) or lower motor neuron (flaccid, hyporeflexic)? If lower motor neuron, is it anterior horn cell, nerve, neuromuscular junction, or muscle?
Step 2: Identify the pattern — Proximal suggests myopathy; distal suggests neuropathy; fatigable suggests neuromuscular junction
Step 3: Consider age of onset — Neonatal/infantile onset often indicates severe or congenital forms; later onset may indicate milder variants
Step 4: Review family history — Pattern of inheritance guides genetic testing
Step 5: Targeted investigations — Creatine kinase, electrodiagnostics, genetic testing, and/or muscle biopsy as indicated

Chronic Weakness — By Anatomical Level

Level	Condition	Approximate Frequency	Key Distinguishing Features
ANTERIOR HORN CELL	Spinal Muscular Atrophy Type 1 (Werdnig-Hoffmann)	1 in 10,000 births	Onset before 6 months; never sits; severe hypotonia; tongue fasciculations; respiratory failure; detectable by newborn screening
	Spinal Muscular Atrophy Type 2	—	Onset 6-18 months; sits but never walks; proximal weakness; tremor of fingers; scoliosis
	Spinal Muscular Atrophy Type 3 (Kugelberg-Welander)	—	Onset after 18 months; walks then loses ability; proximal weakness; normal lifespan possible
PERIPHERAL NERVE	Charcot-Marie-Tooth Disease Type 1 (Demyelinating)	1 in 2,500	Distal weakness, pes cavus, hammer toes, “stork legs,” sensory loss, slow nerve conduction velocities
	Charcot-Marie-Tooth Disease Type 2 (Axonal)	—	Similar to type 1 but nerve conduction velocities normal or mildly slow; axonal loss on EMG
	Hereditary Sensory and Motor Neuropathy variants	Rare	Various genetic forms with additional features (hearing loss, optic atrophy, etc.)
NEUROMUSCULAR JUNCTION	Congenital Myasthenic Syndromes	Rare (1 in 500,000)	Onset infancy/childhood; fatigable weakness; ptosis; feeding difficulties; genetic (not autoimmune)
NEUROMUSCULAR JUNCTION	Juvenile Myasthenia Gravis	1-5 per million children	Autoimmune; fatigable weakness; ptosis; diplopia; positive acetylcholine receptor antibodies in most
MUSCLE (MYOPATHY)	Duchenne Muscular Dystrophy	1 in 3,500-5,000 male births	Boys; onset 2-5 years; proximal weakness; calf pseudohypertrophy; Gowers sign; creatine kinase 10,000-50,000; loss of ambulation by early teens
	Becker Muscular Dystrophy	1 in 18,000 male births	Boys; milder than Duchenne; later onset; ambulation preserved into adulthood; same gene, partial dystrophin
	Limb-Girdle Muscular Dystrophies	Variable (many subtypes)	Proximal weakness; autosomal dominant or recessive; over 30 genetic subtypes identified
	Congenital Muscular Dystrophies	Rare	Present at birth or infancy; hypotonia; contractures; may have brain involvement (Walker-Warburg, muscle-eye-brain disease)
	Congenital Myopathies	1 in 25,000	Central core disease, nemaline myopathy, myotubular myopathy; hypotonia from birth; facial weakness; respiratory involvement; characteristic biopsy findings
	Pompe Disease (Glycogen Storage Disease Type II)	1 in 40,000	Infantile: cardiomegaly, hypotonia, macroglossia, early death without treatment; Late-onset: progressive limb-girdle weakness, respiratory failure

Anatomical Approach to Weakness

Upper Motor Neuron (Brain/Spinal Cord)

Cerebral palsy

Stroke

Brain tumor

Transverse myelitis

Multiple sclerosis

Hereditary spastic paraplegia

Spinal cord compression

Anterior Horn Cell

Spinal muscular atrophy (types 1-4)

Poliomyelitis

Acute flaccid myelitis

West Nile virus

Spinal cord infarction (anterior horn)

Peripheral Nerve

Guillain-Barré syndrome

Chronic inflammatory demyelinating polyneuropathy

Charcot-Marie-Tooth disease

Brachial plexus injury

Toxic neuropathy

Hereditary neuropathies

Neuromuscular Junction and Muscle

Myasthenia gravis

Congenital myasthenic syndromes

Botulism

Muscular dystrophies

Congenital myopathies

Inflammatory myopathies

Metabolic myopathies

Age-Based Differential Diagnosis

Age Group	Most Likely Conditions	Key Considerations
Neonate (0-28 days)	Spinal muscular atrophy type 1, congenital myopathies, congenital muscular dystrophies, congenital myasthenic syndromes, hypoxic-ischemic encephalopathy, neonatal transient myasthenia (maternal antibodies)	Distinguish central from peripheral hypotonia; check for respiratory distress, feeding difficulty; ask about fetal movements and polyhydramnios
Infant (1-12 months)	Spinal muscular atrophy types 1-2, Pompe disease, infant botulism, congenital myopathies	Delayed motor milestones; “floppy baby”; check for tongue fasciculations, paradoxical breathing, cardiomegaly (Pompe)
Toddler (1-3 years)	Duchenne muscular dystrophy, spinal muscular atrophy types 2-3, Guillain-Barré syndrome, dermatomyositis	Gowers sign, calf hypertrophy, gait abnormalities; check creatine kinase in any boy with motor delay
School Age (4-12 years)	Duchenne/Becker muscular dystrophy, Charcot-Marie-Tooth disease, juvenile dermatomyositis, juvenile myasthenia gravis, limb-girdle muscular dystrophies	Sports intolerance, difficulty keeping up with peers, frequent falls; pes cavus suggests neuropathy
Adolescent (13-18 years)	Becker muscular dystrophy, limb-girdle muscular dystrophies, facioscapulohumeral muscular dystrophy, myasthenia gravis, Charcot-Marie-Tooth disease	May minimize symptoms; cosmetic concerns; some muscular dystrophies present in teenage years

Drug-Induced and Toxic Causes of Weakness

Agent	Mechanism	Clinical Features	Recovery
Corticosteroids (chronic)	Steroid myopathy — type II fiber atrophy	Proximal weakness, normal creatine kinase, cushingoid features	Improves with dose reduction over weeks to months
Vincristine	Axonal neuropathy — disrupts microtubules	Distal weakness, sensory symptoms, foot drop, constipation (autonomic)	May be partially reversible with dose reduction; can be permanent
Aminoglycosides	Neuromuscular junction blockade	May unmask or worsen myasthenia gravis; prolonged paralysis post-anesthesia	Reversible when drug stopped; avoid in myasthenia
Statins	Myopathy (mechanism unclear); rarely immune-mediated necrotizing myopathy	Proximal weakness, myalgias, elevated creatine kinase	Usually reversible; immune-mediated form requires immunosuppression
Organophosphates	Acetylcholinesterase inhibition → cholinergic crisis then weakness	Acute: cholinergic symptoms (salivation, lacrimation, urination, defecation); Intermediate syndrome: delayed weakness	Treat with atropine and pralidoxime; supportive care
Botulinum toxin (therapeutic overdose)	Blocks acetylcholine release at neuromuscular junction	Generalized weakness if excessive spread from injection site	Self-limiting over weeks to months
Zidovudine (AZT) and other antiretrovirals	Mitochondrial toxicity	Proximal myopathy, elevated creatine kinase, lactic acidosis	Improves with drug discontinuation

Electrolyte and Metabolic Causes

Abnormality	Clinical Features	Common Causes in Children	Urgency
Hypokalemia	Proximal weakness, areflexia, may cause respiratory weakness; ECG changes (U waves, flattened T waves)	Vomiting, diarrhea, diuretics, renal tubular acidosis, periodic paralysis	Urgent — cardiac arrhythmia risk; replace potassium
Hyperkalemia	Ascending weakness, cardiac arrhythmias (peaked T waves, widened QRS)	Renal failure, tumor lysis, periodic paralysis	Emergency — cardiac arrest risk; immediate treatment
Hypophosphatemia	Proximal weakness, respiratory muscle weakness, confusion	Refeeding syndrome, diabetic ketoacidosis treatment, malnutrition	Urgent — can cause respiratory failure
Hypercalcemia	Weakness, fatigue, constipation, confusion	Hyperparathyroidism, malignancy, vitamin D toxicity	Treat underlying cause; hydration
Hypomagnesemia	Weakness, tremor, tetany, cardiac arrhythmias	Malabsorption, diuretics, refeeding syndrome	Replace magnesium; often accompanies hypokalemia
Thyroid disorders	Hyperthyroidism: proximal weakness; Hypothyroidism: weakness, myoedema, delayed relaxation of reflexes	Graves disease, Hashimoto thyroiditis	Treat underlying thyroid disorder

Quick Reference: “If You See This, Think This”

Clinical Clue	Think This First	Immediate Next Step
Ascending weakness + areflexia + recent gastroenteritis	Guillain-Barré syndrome	Admit; monitor respiratory function; lumbar puncture; nerve conduction studies
Boy + calf pseudohypertrophy + Gowers sign + massively elevated creatine kinase	Duchenne muscular dystrophy	Genetic testing for dystrophin gene; refer to neuromuscular specialist
Floppy infant + tongue fasciculations + alert eyes + paradoxical breathing	Spinal muscular atrophy	SMN1 gene testing (urgent — disease-modifying therapy available)
Ptosis worse in evening + diplopia + fatigable weakness	Myasthenia gravis	Acetylcholine receptor antibody testing; ice pack test; pyridostigmine trial
Infant + constipation + weak cry + dilated pupils + poor feeding	Infant botulism	Admit; stool for C. botulinum toxin and culture; supportive care; human botulism immunoglobulin
Proximal weakness + heliotrope rash + Gottron papules	Juvenile dermatomyositis	Creatine kinase; MRI muscle; consider biopsy; start immunosuppression
Distal weakness + pes cavus + absent ankle reflexes + sensory loss	Charcot-Marie-Tooth disease	Nerve conduction studies; genetic testing (PMP22 duplication most common)
Acute paralysis + recent respiratory illness + asymmetric limb weakness	Acute flaccid myelitis	MRI spine (gray matter T2 changes); supportive care; report to public health
Ascending weakness + recent outdoor exposure + tick found	Tick paralysis	Remove tick immediately — rapid improvement expected
Hypotonic infant + cardiomegaly + macroglossia	Pompe disease	Acid alpha-glucosidase enzyme level; genetic testing; start enzyme replacement therapy urgently
Episodic weakness + triggered by carbohydrates + family history	Hypokalemic periodic paralysis	Check potassium during attack; genetic testing; avoid triggers
Back pain + weakness below a level + bladder dysfunction	Spinal cord compression or transverse myelitis	MRI spine urgently; neurosurgical consultation if compression

Differential Diagnosis Pearls

Creatine kinase is your friend: Massively elevated (greater than 10,000) suggests dystrophinopathy; normal or mildly elevated in neuropathies and neuromuscular junction disorders
Reflexes guide localization: Hyperreflexia = upper motor neuron; areflexia = lower motor neuron; normal reflexes with weakness = early myopathy or neuromuscular junction
Think SMA early: Now treatable — any hypotonic infant should have SMN1 gene testing considered early
Don’t forget the tick: Tick paralysis is completely reversible — always search thoroughly in acute ascending weakness
Check potassium: In any acute weakness, especially if episodic — treatable and potentially life-threatening

6. Diagnostic Investigations

A stepwise, targeted approach guided by clinical localization and suspected etiology

Investigation of the weak child should be guided by clinical localization from history and examination. A stepwise approach — starting with simple, non-invasive tests and proceeding to more specialized investigations — is most efficient. The goal is accurate diagnosis to guide management, genetic counseling, and access to disease-modifying therapies where available.

Baseline Investigations for All Children with Weakness

Investigation	Purpose	What to Look For	Practical Points
Serum Creatine Kinase (CK)	Screen for muscle disease; reflects muscle fiber damage	Normal: less than 200 U/L (varies by lab and age); Mild elevation (500-1,000): inflammatory myopathy, carrier state; Massive elevation (greater than 10,000): Duchenne muscular dystrophy, rhabdomyolysis	May be elevated after exercise, intramuscular injections, or trauma; repeat if borderline; normal CK does not exclude neuromuscular disease
Basic Metabolic Panel	Identify electrolyte disturbances causing weakness	Potassium (hypo- or hyperkalemia), sodium, calcium, magnesium, phosphate, glucose, renal function	Check urgently in acute weakness; potassium critical in periodic paralysis
Complete Blood Count	Screen for infection, malignancy, inflammatory conditions	Leukocytosis (infection), anemia (chronic disease), thrombocytopenia	Non-specific but important baseline
Inflammatory Markers (ESR, CRP)	Screen for inflammatory or infectious causes	Elevated in inflammatory myopathies, infections, vasculitis	Normal in most genetic neuromuscular diseases
Thyroid Function Tests	Exclude thyroid myopathy	Hypothyroidism: elevated TSH, low T4; Hyperthyroidism: suppressed TSH, elevated T4	Both hypo- and hyperthyroidism can cause weakness
Lactate	Screen for mitochondrial disease	Elevated in mitochondrial myopathies; also elevated with poor perfusion, sepsis	Collect without tourniquet; consider lactate:pyruvate ratio

Interpreting Creatine Kinase in Children

Normal range: Generally less than 200 U/L, but varies with age, sex, race, and activity level
Mild elevation (2-10x normal): Inflammatory myopathy, metabolic myopathy, carrier states, recent exercise
Moderate elevation (10-50x normal): Active myopathy, early dystrophy
Massive elevation (greater than 50x normal): Duchenne muscular dystrophy (often greater than 10,000), rhabdomyolysis, acute viral myositis
Normal creatine kinase with weakness: Neuropathy, neuromuscular junction disorder, some congenital myopathies, upper motor neuron lesions

Targeted Investigations by Suspected Localization

If Suspecting Upper Motor Neuron Lesion

First-Line Imaging

MRI Brain with contrast: For suspected brain lesion (stroke, tumor, demyelination); diffusion-weighted imaging for acute stroke
MRI Spine with contrast: For suspected spinal cord pathology; entire spine if level unclear
CT Head: If MRI unavailable or for acute hemorrhage

Additional Investigations

Lumbar puncture: If infection, inflammation, or demyelination suspected (after imaging to exclude mass effect)
MR angiography: For suspected vascular malformation or arterial dissection
Genetic testing: For hereditary spastic paraplegia if chronic progressive course

If Suspecting Anterior Horn Cell Disease (Spinal Muscular Atrophy)

First-Line Tests

SMN1 Gene Testing (deletion/mutation analysis): Diagnostic for spinal muscular atrophy; detects homozygous deletion in approximately 95% of cases
SMN2 Copy Number: Determines disease severity and guides treatment; more copies = milder phenotype

Supporting Tests

Electromyography (EMG): Shows denervation (fibrillations, positive sharp waves) and chronic reinnervation; supports diagnosis but genetic testing is definitive
Creatine kinase: Normal or mildly elevated (usually less than 5x normal)

Urgent: Spinal Muscular Atrophy Diagnosis

Spinal muscular atrophy is now treatable with disease-modifying therapies (nusinersen, onasemnogene abeparvovec, risdiplam). Early treatment, ideally pre-symptomatic, dramatically improves outcomes. If spinal muscular atrophy is suspected:

Order SMN1 genetic testing immediately — do not wait for EMG
Results typically available in 1-2 weeks; expedite if possible
Many regions have newborn screening for spinal muscular atrophy — check screening status
Refer to neuromuscular specialist urgently upon diagnosis

If Suspecting Peripheral Neuropathy

First-Line Tests

Nerve Conduction Studies (NCS): Differentiates demyelinating (slow velocities, prolonged distal latencies, conduction block) from axonal (reduced amplitudes, normal velocities) neuropathy
Electromyography (EMG): Shows denervation in affected muscles; helps determine severity and chronicity

Second-Line Tests

Lumbar puncture: Elevated protein with normal cell count (albuminocytologic dissociation) in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
Genetic testing: For suspected Charcot-Marie-Tooth disease — PMP22 duplication/deletion panel first; expanded panel if negative
Anti-ganglioside antibodies: Anti-GM1 in motor variants of Guillain-Barré syndrome; anti-GQ1b in Miller Fisher syndrome

Nerve Conduction Study Pattern	Interpretation	Conditions
Slow conduction velocities (less than 38 m/s in arms)	Demyelinating neuropathy	Charcot-Marie-Tooth type 1, Guillain-Barré syndrome (AIDP variant), chronic inflammatory demyelinating polyneuropathy
Reduced amplitudes with normal velocities	Axonal neuropathy	Charcot-Marie-Tooth type 2, axonal Guillain-Barré syndrome (AMAN/AMSAN), toxic neuropathy
Conduction block	Focal demyelination	Acquired demyelinating neuropathies (Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy)

If Suspecting Neuromuscular Junction Disorder

First-Line Tests

Acetylcholine receptor (AChR) antibodies: Positive in approximately 50% of juvenile myasthenia gravis (lower than adults); highly specific
Muscle-specific kinase (MuSK) antibodies: Check if AChR negative; associated with bulbar-predominant myasthenia
Repetitive nerve stimulation: Decremental response (greater than 10% decrement at 3 Hz) supports diagnosis

Additional Tests

Single-fiber EMG: Most sensitive test; shows increased jitter and blocking; requires cooperation (difficult in young children)
CT/MRI chest: To evaluate for thymoma (rare in children but important to exclude)
Edrophonium (Tensilon) test: Rarely used now due to cardiac risks; ice pack test is safer alternative
Genetic testing: For congenital myasthenic syndromes if antibodies negative and onset in infancy

If Suspecting Myopathy (Muscle Disease)

First-Line Tests

Creatine kinase: Elevated in most myopathies; degree of elevation helps narrow differential
Genetic testing: Often first-line for suspected inherited myopathies; dystrophin gene analysis for suspected Duchenne/Becker; neuromuscular gene panels available
EMG: Myopathic pattern (short duration, low amplitude, polyphasic motor unit potentials); early recruitment

Second-Line Tests

Muscle MRI: Shows pattern of muscle involvement; guides biopsy site; characteristic patterns in some conditions
Muscle biopsy: When diagnosis remains unclear after genetic testing; provides histological and immunohistochemical information
Specific enzyme assays: Acid alpha-glucosidase for Pompe disease (can be done on dried blood spot)

Suspected Condition	Key Investigation	Expected Finding	Notes
Duchenne Muscular Dystrophy	Dystrophin gene (DMD) analysis	Deletion, duplication, or point mutation in DMD gene	Confirms diagnosis in greater than 99%; determines eligibility for exon-skipping therapies
Becker Muscular Dystrophy	Dystrophin gene analysis	In-frame mutation allowing partial dystrophin production	Same gene as Duchenne; mutation type predicts severity
Limb-Girdle Muscular Dystrophy	Neuromuscular gene panel	Mutations in one of greater than 30 causative genes	Biopsy may help if genetic testing inconclusive
Pompe Disease	Acid alpha-glucosidase enzyme activity (dried blood spot or lymphocytes)	Reduced or absent enzyme activity	Confirm with GAA gene sequencing; early diagnosis critical for enzyme replacement therapy
Juvenile Dermatomyositis	Muscle enzymes (CK, aldolase, LDH, AST), MRI muscle, myositis-specific antibodies	Elevated enzymes; muscle edema on MRI; anti-Mi-2, anti-NXP-2, or anti-MDA5 antibodies	Biopsy if diagnosis uncertain; shows perifascicular atrophy
Congenital Myopathies	Genetic testing (RYR1, MTM1, NEB, ACTA1 genes)	Pathogenic variant in causative gene	Biopsy shows characteristic features (central cores, nemaline rods, central nuclei); genetics increasingly first-line

Cerebrospinal Fluid Analysis

Lumbar puncture is indicated when infection, inflammation, or demyelination is suspected. Always perform neuroimaging first to exclude mass lesions.

Condition	CSF Protein	CSF Cell Count	Other Findings
Guillain-Barré Syndrome	Elevated (often greater than 0.45 g/L); may be normal early	Normal (less than 5 cells/μL) — albuminocytologic dissociation	Cell count greater than 50 should prompt consideration of alternative diagnoses (HIV, Lyme, CMV)
Chronic Inflammatory Demyelinating Polyneuropathy	Elevated	Normal or mildly elevated	Similar pattern to Guillain-Barré syndrome
Transverse Myelitis	Normal or mildly elevated	Pleocytosis (lymphocytic predominance)	Oligoclonal bands may be present; exclude infectious myelitis
Acute Flaccid Myelitis	Normal or mildly elevated	Pleocytosis common	Enterovirus PCR often negative in CSF despite clinical picture

Electrodiagnostic Studies in Children

Pediatric Considerations for Electrodiagnostics

Age-appropriate normal values: Nerve conduction velocities are lower in infants and increase with myelination; adult values reached by age 3-5 years
Cooperation: EMG requires relaxation and voluntary contraction — challenging in young children; may need sedation or general anesthesia
Timing: In acute denervation, fibrillation potentials may not appear for 2-3 weeks; early study may be falsely negative
Expertise required: Should be performed by pediatric neurophysiologist experienced with children
Genetic testing often preferred: For many inherited conditions, genetic testing is now more informative and less distressing than EMG

EMG/NCS Pattern	Interpretation	Conditions
Fibrillations + positive sharp waves + large motor units	Chronic denervation with reinnervation (neurogenic)	Spinal muscular atrophy, chronic neuropathy, motor neuron disease
Short-duration, low-amplitude, polyphasic motor units with early recruitment	Myopathic pattern	Muscular dystrophies, inflammatory myopathies, congenital myopathies
Decremental response to repetitive stimulation at 3 Hz	Neuromuscular junction defect (postsynaptic)	Myasthenia gravis
Incremental response to high-frequency stimulation (20-50 Hz)	Neuromuscular junction defect (presynaptic)	Botulism, Lambert-Eaton myasthenic syndrome
Myotonic discharges	Waxing and waning “dive bomber” sound	Myotonic dystrophy, myotonia congenita

Muscle Biopsy

Muscle biopsy is now less commonly needed due to advances in genetic testing but remains valuable when diagnosis is unclear or genetic testing is inconclusive.

Indications for Muscle Biopsy

Suspected inflammatory myopathy (dermatomyositis, polymyositis)
Genetic testing inconclusive or negative
Need for protein analysis (dystrophin immunostaining, enzyme histochemistry)
Suspected metabolic myopathy (glycogen storage, lipid storage, mitochondrial)
Congenital myopathy with characteristic histopathology

Practical Considerations

Site selection: Moderately affected muscle (not end-stage); MRI guidance helpful
Avoid: Recently needled muscles (EMG artifacts)
Processing: Fresh frozen tissue for histochemistry and immunohistochemistry; fixed tissue for electron microscopy
Expertise: Requires specialized neuromuscular pathology interpretation

Genetic Testing Approach

Modern Approach to Genetic Diagnosis:

Genetic testing has revolutionized diagnosis of neuromuscular disorders. For many conditions, genetic testing is now first-line, replacing or preceding invasive tests like muscle biopsy.

Single gene testing: When clinical picture strongly suggests a specific condition (e.g., SMN1 for spinal muscular atrophy, DMD for Duchenne)
Gene panels: Neuromuscular panels test 50-200+ genes simultaneously; efficient for heterogeneous conditions
Whole exome sequencing: When panels negative; identifies variants across all coding regions
Whole genome sequencing: Increasingly available; detects intronic variants and structural changes

Clinical Scenario	Recommended Genetic Testing	Turnaround Time
Suspected spinal muscular atrophy	SMN1 deletion/mutation analysis with SMN2 copy number	1-2 weeks (expedite if possible)
Boy with elevated creatine kinase and proximal weakness	DMD gene sequencing (deletion/duplication first, then full sequencing)	2-4 weeks
Suspected Charcot-Marie-Tooth disease	PMP22 duplication/deletion first; if negative, CMT gene panel	2-4 weeks
Congenital myopathy	Congenital myopathy gene panel (includes RYR1, MTM1, NEB, ACTA1, etc.)	4-8 weeks
Limb-girdle weakness, unclear etiology	Comprehensive neuromuscular gene panel	4-8 weeks
Panel-negative, high clinical suspicion	Whole exome or whole genome sequencing	8-16 weeks

Special Investigations for Specific Scenarios

Acute Weakness — Emergency Workup

Urgent Investigations for Acute Weakness

Potassium, calcium, magnesium, phosphate: Electrolyte-induced weakness can be rapidly fatal
Glucose: Hypoglycemia can cause weakness
MRI spine: If cord compression suspected — this is a surgical emergency
Lumbar puncture: After imaging, if Guillain-Barré syndrome or infection suspected
Respiratory function: Forced vital capacity, negative inspiratory force — determines need for ICU
ECG: Arrhythmias in electrolyte disturbances, autonomic dysfunction
Tick search: Physical examination finding, not a test — but critical not to miss

Infant Botulism Workup

Stool for Clostridium botulinum toxin and culture: Gold standard; may take days for result
Electrophysiology: Brief, small-amplitude motor unit potentials; incremental response to rapid repetitive stimulation
Serum toxin assay: Usually negative in infant botulism (toxin produced in gut)
Do not wait for test results to treat: If clinical suspicion high, request human botulism immune globulin (BabyBIG) early

Monitoring in Neuromuscular Disease

Assessment	Conditions Requiring Monitoring	Frequency
Pulmonary function tests (spirometry)	Duchenne muscular dystrophy, spinal muscular atrophy, all progressive neuromuscular diseases	Every 6-12 months; more frequently if declining
Sleep study (polysomnography)	If symptoms of nocturnal hypoventilation (morning headache, daytime somnolence)	As clinically indicated; consider annually in at-risk patients
Echocardiography and ECG	Duchenne muscular dystrophy, Becker muscular dystrophy, limb-girdle muscular dystrophies, Pompe disease, Friedreich ataxia	Annually or as recommended for specific condition
Spine X-ray for scoliosis	Spinal muscular atrophy, Duchenne muscular dystrophy, congenital myopathies	Annually during growth; more frequently if curve progressing
Bone density (DEXA scan)	Patients on chronic corticosteroids, non-ambulatory patients	Every 1-2 years

Investigation Pearls

Creatine kinase first: Simple, inexpensive, and highly informative — always check in suspected myopathy
Genetic testing is transforming diagnosis: Consider early, especially for spinal muscular atrophy (treatable) and conditions where biopsy can be avoided
Don’t delay for test results in emergencies: Treat tick paralysis (remove tick), suspected botulism (BabyBIG), and Guillain-Barré syndrome (IVIG/plasmapheresis) based on clinical suspicion
EMG is not always needed: If genetic testing will be definitive, EMG may add discomfort without changing management
Monitor respiratory function: Many neuromuscular diseases cause insidious respiratory failure — don’t wait for symptoms
Cardiac involvement: Remember that many myopathies affect heart muscle — echocardiography is essential

7. Pattern Recognition and Clinical Decision-Making

Practical algorithms and decision pathways for the weak child

Clinical decision-making in pediatric weakness requires rapid triage of emergencies, systematic localization, and efficient diagnostic workup. This section provides practical algorithms to guide management from the emergency department to the outpatient clinic.

Step 1: Is This Urgent?

The first priority is identifying life-threatening conditions requiring immediate intervention.

Clinical Scenario	Urgency Level	Immediate Action
Respiratory distress, paradoxical breathing, weak cough, declining oxygen saturation	EMERGENT	ICU admission; prepare for intubation; measure forced vital capacity if possible (intubate if less than 15 mL/kg); do not delay for diagnostics
Rapidly ascending weakness over hours	EMERGENT	Admit to ICU; monitor respiratory function every 2-4 hours; search for tick; lumbar puncture; prepare for IVIG or plasmapheresis (Guillain-Barré syndrome)
Weakness with back pain, sensory level, bladder/bowel dysfunction	EMERGENT	MRI spine immediately; neurosurgical consultation if compression; high-dose steroids if tumor suspected
Sudden hemiparesis with facial weakness	EMERGENT	Activate stroke protocol; CT head to exclude hemorrhage; MRI with diffusion-weighted imaging; consider thrombolysis/thrombectomy in appropriate cases
Infant with hypotonia, weak cry, constipation, dilated pupils	EMERGENT	Suspect botulism; ICU admission; request human botulism immune globulin (BabyBIG) immediately; supportive care; stool for toxin/culture
Weakness with severe hypokalemia (less than 2.5 mEq/L) or hyperkalemia (greater than 6.5 mEq/L)	EMERGENT	Cardiac monitoring; ECG; treat electrolyte disturbance immediately; identify and treat underlying cause
Bulbar weakness with drooling, aspiration, inability to swallow	URGENT	NPO; aspiration precautions; consider nasogastric tube; evaluate for myasthenic crisis, botulism, Guillain-Barré syndrome
Progressive weakness over days with preceding infection	URGENT	Admit for observation; monitor respiratory function; workup for Guillain-Barré syndrome, acute flaccid myelitis, transverse myelitis
Floppy infant with poor feeding, not meeting milestones	URGENT	Urgent SMN1 genetic testing (spinal muscular atrophy is treatable); assess respiratory status; evaluate feeding safety
Chronic progressive weakness, ambulatory, no respiratory symptoms	ROUTINE	Outpatient neurology referral; baseline investigations (creatine kinase, metabolic panel); genetic testing as indicated

Step 2: Localize the Lesion

Use clinical findings to determine whether the weakness is upper motor neuron, lower motor neuron, or a combination.

Upper Motor Neuron Pattern

Findings: Spasticity (may be flaccid acutely), hyperreflexia, positive Babinski, no atrophy early, pyramidal distribution

Proceed to: Brain and/or spinal cord imaging (MRI with contrast)

Consider: Stroke, tumor, demyelination, transverse myelitis, spinal cord compression

Lower Motor Neuron Pattern

Findings: Flaccidity, hyporeflexia or areflexia, atrophy, fasciculations (if anterior horn cell)

Proceed to: Step 3 — further localize within lower motor neuron

Consider: Anterior horn cell disease, neuropathy, neuromuscular junction disorder, myopathy

Step 3: Localize Within the Lower Motor Neuron

Feature	Anterior Horn Cell	Peripheral Nerve	Neuromuscular Junction	Muscle
Distribution	Proximal more than distal; often asymmetric early	Distal more than proximal (length-dependent) or nerve territory	Ocular, bulbar, proximal; fatigable	Proximal; symmetric
Atrophy	Prominent; early	Present; distal	Minimal or absent	Variable; may have pseudohypertrophy
Fasciculations	Present (especially tongue)	May be present	Absent	Absent
Sensory involvement	Absent	Present	Absent	Absent
Reflexes	Absent	Reduced or absent	Normal (may be reduced late)	Normal early; reduced late
Creatine kinase	Normal or mildly elevated	Normal	Normal	Elevated (often markedly)
Key investigation	SMN1 gene testing; EMG	Nerve conduction studies; genetic testing	AChR antibodies; repetitive stimulation	Creatine kinase; genetic testing; biopsy

Step 4: Follow the Appropriate Algorithm by Tempo

Algorithm A: Acute Weakness (Hours to Days)

Clinical Scenario	Most Likely Diagnosis	Immediate Action
Ascending symmetric weakness + areflexia + recent infection	Guillain-Barré syndrome	ICU if respiratory compromise; lumbar puncture; nerve conduction studies; IVIG or plasmapheresis
Acute limb weakness + preceding respiratory illness + asymmetric	Acute flaccid myelitis	MRI spine (gray matter changes); supportive care; report to public health
Bilateral leg weakness + sensory level + back pain + urinary retention	Transverse myelitis or cord compression	MRI spine urgently; if compression — neurosurgery; if inflammation — high-dose steroids
Ascending weakness + tick found on body	Tick paralysis	Remove tick immediately; expect rapid improvement; supportive care
Descending weakness + bulbar symptoms + dilated pupils + constipation (infant)	Botulism	ICU; request BabyBIG; stool for toxin; supportive care
Episodic weakness + triggered by carbohydrates or cold + family history	Periodic paralysis	Check potassium urgently; treat electrolyte abnormality; genetic testing
Calf pain + difficulty walking + recent flu-like illness	Acute viral myositis	Check creatine kinase (elevated but usually less than 10,000); supportive care; monitor for rhabdomyolysis

Algorithm B: Subacute Weakness (Days to Weeks)

Clinical Scenario	Most Likely Diagnosis	Action
Proximal weakness + characteristic rash (heliotrope eyelids, Gottron papules)	Juvenile dermatomyositis	Creatine kinase, aldolase; MRI muscle; myositis antibodies; start immunosuppression (steroids)
Fatigable weakness + ptosis + diplopia worse by evening	Myasthenia gravis	AChR antibodies; repetitive nerve stimulation; CT chest (thymoma); pyridostigmine trial
Progressive symmetric weakness more than 8 weeks + areflexia + elevated CSF protein	Chronic inflammatory demyelinating polyneuropathy	Nerve conduction studies; lumbar puncture; IVIG or steroids
Progressive weakness + back pain worse at night + weight loss	Spinal cord or brain tumor	MRI brain and spine with contrast; oncology referral

Algorithm C: Chronic Weakness (Months to Years)

Clinical Scenario	Most Likely Diagnosis	Action
Floppy infant + tongue fasciculations + paradoxical breathing + alert	Spinal muscular atrophy	URGENT SMN1 genetic testing; refer to neuromuscular specialist immediately; disease-modifying therapy available
Boy + proximal weakness + calf pseudohypertrophy + Gowers sign + CK greater than 10,000	Duchenne muscular dystrophy	DMD gene testing; refer to neuromuscular center; start corticosteroids; cardiac and pulmonary monitoring
Distal weakness + pes cavus + hammer toes + absent ankle reflexes + sensory loss	Charcot-Marie-Tooth disease	Nerve conduction studies; genetic testing (PMP22 first); orthotics; physical therapy
Hypotonic infant + cardiomegaly + macroglossia + elevated creatine kinase	Pompe disease	Acid alpha-glucosidase enzyme level; GAA gene testing; enzyme replacement therapy urgently if confirmed
Proximal weakness + myopathic facies + high-arched palate + respiratory involvement from infancy	Congenital myopathy	Genetic testing (congenital myopathy panel); muscle biopsy if genetics inconclusive; monitor respiratory function

“What Do I Do If…” Decision Reference

Clinical Situation	Immediate Action	Next Step
Forced vital capacity less than 20 mL/kg or declining rapidly	Transfer to ICU; prepare for intubation	Non-invasive ventilation may temporize; treat underlying cause
Child with known muscular dystrophy develops arrhythmia	ECG; cardiology consultation; telemetry monitoring	Echocardiography; adjust cardiac medications; avoid QT-prolonging drugs
Negative genetic testing but strong clinical suspicion for genetic condition	Consider muscle biopsy for protein analysis	Whole exome or genome sequencing; RNA sequencing; repeat genetic testing as technology improves
Child with Guillain-Barré syndrome not improving after IVIG	Consider second course of IVIG or plasmapheresis	Review diagnosis (could this be chronic inflammatory demyelinating polyneuropathy?); supportive care; rehabilitation
Myasthenic patient deteriorating after starting new medication	Stop offending drug immediately	Many drugs worsen myasthenia (aminoglycosides, beta-blockers, magnesium, fluoroquinolones) — review all medications
Parents decline genetic testing for suspected Duchenne muscular dystrophy	Explore concerns; explain implications for treatment and family planning	Muscle biopsy can confirm dystrophin deficiency; offer genetic counseling
Hypotonic infant with normal creatine kinase and negative spinal muscular atrophy testing	Expand differential to include central hypotonia, Prader-Willi syndrome, congenital myopathies	Chromosomal microarray; methylation studies; congenital myopathy gene panel; brain MRI
Child with acute weakness — no tick found but history suspicious	Search again — carefully check scalp, behind ears, hairline, groin, interdigital spaces	Ticks can be very small (nymph stage); consider dermoscopy; if found, removal leads to rapid improvement

When to Involve Subspecialists

Specialist	When to Refer	Urgency
Pediatric Neurologist	All cases of unexplained weakness; interpretation of electrodiagnostics and genetic testing; management of neuromuscular disease	Urgent if acute or rapidly progressive; routine for chronic stable weakness
Pediatric Intensivist	Respiratory compromise; rapidly ascending weakness; need for ventilatory support; autonomic instability	Emergent
Neurosurgeon	Spinal cord compression; spinal tumor; need for diagnostic biopsy	Emergent if cord compression; urgent for tumor
Cardiologist	Suspected or confirmed cardiomyopathy in muscular dystrophy, Pompe disease; arrhythmias; cardiac involvement of myopathy	Urgent if symptomatic; routine for surveillance
Pulmonologist	Respiratory muscle weakness; sleep-disordered breathing; need for non-invasive ventilation	Urgent if symptomatic; routine for monitoring
Geneticist/Genetic Counselor	Confirmed genetic diagnosis; discussion of inheritance and recurrence risk; prenatal testing options	Routine but important for family counseling
Physical Medicine and Rehabilitation	Functional optimization; orthotic needs; equipment evaluation; spasticity management	Routine; essential for chronic neuromuscular disease
Orthopedic Surgery	Scoliosis management; contracture release; hip surveillance; spinal fusion evaluation	Routine for most; urgent if rapid curve progression

Troubleshooting: The Child Who Isn’t Improving

Ask These Questions

Is the diagnosis correct? — Revisit history and examination; consider alternative diagnoses
Is there a second diagnosis? — Some patients have more than one condition (e.g., myasthenia plus thyroid disease)
Is treatment adequate? — Duration, dosing, compliance all matter
For Guillain-Barré syndrome: Some patients have prolonged course; consider axonal variant (AMAN) which has slower recovery
For inflammatory myopathy: Is this refractory to steroids? Consider other immunosuppressants; rule out malignancy
For genetic conditions: Disease-modifying therapies may slow but not reverse progression; set realistic expectations
Are complications being managed? — Respiratory, cardiac, nutritional, orthopedic issues all affect outcomes

8. Clinical Pearls and Pitfalls

Practical wisdom — learn from successes and avoid common mistakes

Must-Know Clinical Pearls

Spinal muscular atrophy is now treatable: Early diagnosis with SMN1 genetic testing is critical. Disease-modifying therapies (nusinersen, onasemnogene, risdiplam) dramatically improve outcomes when started early, ideally pre-symptomatically. Check if newborn screening was performed.

Creatine kinase is your best screening test for myopathy: A simple, inexpensive blood test that can be markedly elevated years before clinical diagnosis in Duchenne muscular dystrophy. Check creatine kinase in any boy with motor delay, frequent falls, or calf enlargement.

Tongue fasciculations are highly specific for anterior horn cell disease: In a hypotonic infant, carefully observe the tongue at rest inside the mouth. Fasciculations (fine, irregular twitching) strongly suggest spinal muscular atrophy — order genetic testing immediately.

Reflexes guide localization: Hyperreflexia means upper motor neuron; areflexia means lower motor neuron. Normal reflexes with weakness suggest early myopathy or neuromuscular junction disease. This single finding can narrow your differential dramatically.

Fatigability is the hallmark of neuromuscular junction disorders: If weakness worsens with activity and improves with rest, think myasthenia gravis. Test with sustained upgaze (ptosis worsens) or repetitive grip (strength declines). The ice pack test is a simple bedside diagnostic tool.

Tick paralysis is completely reversible — but you must find the tick: In any child with acute ascending weakness, perform a thorough search of the entire body including scalp, behind ears, hairline, and groin. Tick removal leads to rapid improvement within hours.

Trust parental concern: “My child seems weaker” from an attentive parent is often correct even when your examination is normal. Parents notice subtle changes in motor function before objective weakness is detectable. Take this seriously and investigate appropriately.

Paradoxical breathing is a warning sign of respiratory failure: When the abdomen rises while the chest falls during inspiration, diaphragm weakness is present. This is an indication for urgent respiratory support — do not wait for blood gas abnormalities.

Genetic testing has transformed diagnosis: For many inherited neuromuscular conditions, genetic testing is now first-line and can obviate the need for muscle biopsy. Order early when clinical suspicion is high — results guide treatment, prognosis, and family counseling.

Multidisciplinary care improves outcomes: Children with chronic neuromuscular disease benefit from coordinated care involving neurology, pulmonology, cardiology, orthopedics, physical therapy, nutrition, and psychosocial support. Neuromuscular centers provide comprehensive care.

Critical Pitfalls to Avoid

Missing the tick in tick paralysis: Tick paralysis is completely reversible with tick removal, but fatal if the tick remains attached. Always perform a thorough search in any child with acute ascending weakness — ticks can be tiny (nymph stage) and hide in hair.

Delaying spinal muscular atrophy diagnosis: Every day matters. Disease-modifying therapies are most effective when started before symptoms progress. If a floppy infant has tongue fasciculations or any infant has unexplained hypotonia, order SMN1 genetic testing immediately — do not wait for EMG.

Attributing motor delay to “laziness” or “late bloomer”: True motor delay always deserves investigation. A boy who isn’t walking by 18 months or who uses Gowers maneuver to rise from the floor may have Duchenne muscular dystrophy. Check creatine kinase early — it’s simple and informative.

Failing to monitor respiratory function in Guillain-Barré syndrome: Patients can deteriorate rapidly. Monitor forced vital capacity every 2-4 hours during the progressive phase. Intubate early (FVC less than 15-20 mL/kg) — don’t wait for respiratory arrest.

Assuming normal creatine kinase excludes neuromuscular disease: Neuropathies, neuromuscular junction disorders, and some congenital myopathies have normal creatine kinase. A normal result narrows the differential but doesn’t exclude serious pathology.

Giving aminoglycosides or other contraindicated drugs to patients with myasthenia gravis: Many common medications worsen myasthenia (aminoglycosides, fluoroquinolones, beta-blockers, magnesium sulfate, neuromuscular blocking agents). Always check before prescribing.

Missing infant botulism: The triad of constipation, weak cry, and poor feeding in a previously healthy infant should trigger suspicion. Dilated pupils are a clue. Request human botulism immune globulin (BabyBIG) immediately if suspected — don’t wait for laboratory confirmation.

Forgetting to check potassium in episodic weakness: Periodic paralysis can cause life-threatening hypokalemia or hyperkalemia. Always check electrolytes urgently in any child with acute unexplained weakness, especially if episodic.

Not considering cardiac involvement in myopathies: Duchenne muscular dystrophy, Becker muscular dystrophy, and Pompe disease all cause cardiomyopathy. Regular echocardiography is essential — cardiac complications are a major cause of morbidity and mortality.

Dismissing weakness as “functional” without thorough evaluation: While psychogenic weakness exists, many children with early neuromuscular disease have subtle findings initially. Perform a complete evaluation including creatine kinase before attributing weakness to non-organic causes.

Key Takeaways

Weakness in children ranges from benign to life-threatening — rapid triage using red flags identifies emergencies requiring immediate intervention
Tempo of onset guides differential diagnosis — acute (Guillain-Barré syndrome, botulism, cord compression), subacute (dermatomyositis, myasthenia), chronic (muscular dystrophies, SMA, neuropathies)
Localization determines investigation — upper motor neuron (imaging), anterior horn cell (SMN1 gene), neuropathy (nerve conduction studies), neuromuscular junction (antibodies), muscle (creatine kinase, genetics)
Pattern of weakness provides diagnostic clues — proximal suggests myopathy, distal suggests neuropathy, fatigable suggests neuromuscular junction, ascending suggests Guillain-Barré syndrome
Spinal muscular atrophy is treatable — early diagnosis and treatment dramatically improve outcomes; order SMN1 genetic testing promptly in any hypotonic infant
Creatine kinase is the best screening test for myopathy — cheap, accessible, and often markedly elevated in dystrophinopathies before clinical diagnosis
Respiratory monitoring is critical in acute weakness — measure forced vital capacity, watch for paradoxical breathing, and have a low threshold for ICU admission
Genetic testing has transformed diagnosis — often first-line for inherited conditions, guiding treatment, prognosis, and family counseling
Always search for a tick — tick paralysis is completely reversible but easily missed; examine the entire body including scalp
Multidisciplinary care optimizes outcomes — neuromuscular disease affects respiratory, cardiac, orthopedic, and nutritional function; comprehensive care improves quality of life and survival

Quick Reference Algorithm

Systematic Approach to the Weak Child:

Assess for emergency: Respiratory compromise? Rapid progression? Cord compression? → ICU admission and urgent intervention
Determine tempo: Acute (hours-days), subacute (weeks), or chronic (months-years) → guides differential
Localize the lesion: Upper motor neuron (spastic, hyperreflexic) vs lower motor neuron (flaccid, hyporeflexic)
If lower motor neuron, further localize: Anterior horn cell, nerve, neuromuscular junction, or muscle — use distribution, reflexes, sensory involvement, and creatine kinase
Obtain baseline investigations: Creatine kinase, metabolic panel, complete blood count; add specific tests based on localization
Order targeted testing: SMN1 gene for suspected SMA, DMD gene for suspected Duchenne, AChR antibodies for suspected myasthenia, nerve conduction studies for neuropathy
Always search for a tick in acute ascending weakness — removal is curative
Monitor respiratory and cardiac function: Many neuromuscular conditions cause insidious cardiopulmonary compromise
Refer to neuromuscular specialist: For comprehensive evaluation, genetic counseling, and access to disease-modifying therapies
Coordinate multidisciplinary care: Pulmonology, cardiology, orthopedics, rehabilitation, nutrition, and psychosocial support optimize long-term outcomes